Free Trial

Andlauer Healthcare Group (TSE:AND) PT Lowered to C$46.00

→ Gold Set to EXPLODE! (From Gold Safe Exchange) (Ad)
Andlauer Healthcare Group logo with Industrials background

Andlauer Healthcare Group (TSE:AND - Free Report) had its price objective lowered by Scotiabank from C$47.50 to C$46.00 in a research report released on Monday, BayStreet.CA reports. The brokerage currently has an outperform rating on the stock.

Several other research firms have also recently weighed in on AND. TD Securities cut their price objective on Andlauer Healthcare Group from C$54.00 to C$52.00 and set a buy rating for the company in a research report on Monday. Royal Bank of Canada cut their price target on Andlauer Healthcare Group from C$43.00 to C$41.00 and set a sector perform rating for the company in a report on Monday. National Bankshares raised their price objective on shares of Andlauer Healthcare Group from C$46.00 to C$47.00 and gave the stock a sector perform rating in a research note on Thursday, March 7th. Eight Capital cut their target price on shares of Andlauer Healthcare Group from C$62.00 to C$58.00 and set a buy rating for the company in a research note on Thursday, March 7th. Finally, CIBC decreased their price target on shares of Andlauer Healthcare Group from C$52.00 to C$50.00 and set an outperform rating on the stock in a research report on Monday. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat, Andlauer Healthcare Group currently has a consensus rating of Moderate Buy and an average target price of C$49.43.


View Our Latest Stock Report on Andlauer Healthcare Group

Andlauer Healthcare Group Stock Performance

Andlauer Healthcare Group stock traded down C$0.74 during trading hours on Monday, reaching C$40.31. 54,453 shares of the company were exchanged, compared to its average volume of 26,377. Andlauer Healthcare Group has a 12 month low of C$36.76 and a 12 month high of C$48.80. The firm has a market cap of C$785.24 million, a price-to-earnings ratio of 26.01 and a beta of 0.69. The company has a current ratio of 2.52, a quick ratio of 1.66 and a debt-to-equity ratio of 27.24. The stock has a 50-day moving average of C$42.09 and a 200 day moving average of C$40.49.

Andlauer Healthcare Group (TSE:AND - Get Free Report) last posted its quarterly earnings data on Tuesday, March 5th. The company reported C$0.44 earnings per share (EPS) for the quarter, missing the consensus estimate of C$0.49 by C($0.05). The firm had revenue of C$169.07 million for the quarter, compared to the consensus estimate of C$165.00 million. Andlauer Healthcare Group had a return on equity of 14.53% and a net margin of 10.21%. As a group, research analysts anticipate that Andlauer Healthcare Group will post 1.8439434 earnings per share for the current year.

Andlauer Healthcare Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Thursday, March 28th were paid a $0.10 dividend. The ex-dividend date was Wednesday, March 27th. This represents a $0.40 dividend on an annualized basis and a yield of 0.99%. This is a boost from Andlauer Healthcare Group's previous quarterly dividend of $0.09. Andlauer Healthcare Group's payout ratio is presently 23.23%.

Andlauer Healthcare Group Company Profile

(Get Free Report)

Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.

Read More

Analyst Recommendations for Andlauer Healthcare Group (TSE:AND)

Should you invest $1,000 in Andlauer Healthcare Group right now?

Before you consider Andlauer Healthcare Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Andlauer Healthcare Group wasn't on the list.

While Andlauer Healthcare Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Featured Articles and Offers

Search Headlines: